Beckwith-Wiedemann syndrome (BWS) is an epigenetic overgrowth disorder and cancer predisposition syndrome caused by imprinting defects of chromosome 11p15.5-11p15.4. BWS should be considered in children with atypical presentations of embryonal tumors regardless of clinical phenotype. Risk of malignancy correlates with specific molecular subgroups of BWS making molecular subclassification important for appropriate cancer screening. We report the first case of concurrent embryonal tumors in a phenotypically normal child, leading to the diagnosis of BWS with paternal uniparental disomy and describe the molecular classification of BWS as it relates to malignancy risk, along with approach to management.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000002593DOI Listing

Publication Analysis

Top Keywords

leading diagnosis
8
beckwith-wiedemann syndrome
8
embryonal tumors
8
bws
5
concurrent hepatoblastoma
4
hepatoblastoma wilms
4
wilms tumor
4
tumor leading
4
diagnosis beckwith-wiedemann
4
syndrome beckwith-wiedemann
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!